The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials

BACKGROUND: Topiramate is approved for the prophylaxis (prevention) of migraine headache in adults. The most common adverse events in the three pivotal, randomized, double-blind, placebo-controlled trials were paresthesia, fatigue, cognitive impairment, anorexia, nausea, and taste alteration. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahlöf, Carl, Loder, Elizabeth, Diamond, Merle, Rupnow, Marcia, Papadopoulos, George, Mao, Lian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2093930/
https://www.ncbi.nlm.nih.gov/pubmed/17916258
http://dx.doi.org/10.1186/1477-7525-5-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2093930/
https://www.ncbi.nlm.nih.gov/pubmed/17916258
http://dx.doi.org/10.1186/1477-7525-5-56

Ejemplares similares